Of blood and guts: Association between Helicobacter pylori and the gastric microcirculation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 9, 2003, Pages 1010-1017

  Kalia, Neena ^a,c   Bardhan, Karna Dev ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^c Department of Biomedical Sciences Alfred Denny Building ^*  (United Kingdom)

Author keywords

Helicobacter pylori; Leukocytes; Microcirculation; Pathogenesis; Platelets

Indexed keywords

CD11 ANTIGEN; CD18 ANTIGEN; CELL ADHESION MOLECULE; HISTAMINE; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; SEROTONIN; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2;

CELL ACTIVITY; DISEASE ASSOCIATION; EMBOLISM; GASTRITIS; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; IN VIVO STUDY; ISCHEMIA; ISCHEMIC HEART DISEASE; LEUKOCYTE; MICROCIRCULATION; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH BLOOD FLOW; STOMACH MUCOSA; STOMACH ULCER; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0141506871     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03062.x     Document Type: Review

References (74)

1. McColl KEL, Fullarton GM, Nujumi AME et al. Lowered gastrin and gastric acidity after eradication of Campylobacter pylori in duodenal ulcer. Lancet 1989; 2: 499-500.
2. Moss SF, Legon S, Bishop A et al. Effect of Helicobacter pylori on gastric somatostatin in peptic ulcer disease. Lancet 1992; 340: 930-2.
3. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992; 102: 720-7.
4. Levi S, Beardshall K, Swift I et al. Antral Helicobacter pylori, hypergastrinaemia and duodenal ulcer. BMJ 1989; 299: 1504-5.
5. Slominay BL, Slomiany A. Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J. Clin. Gastroenterol. 1992; 142: S114-S121.
6. Haruma K, Kawaguchi H, Yoshihara H et al. Relationship between Helicobacter pylori infection and gastric acid secretion in young healthy subjects. J. Clin. Gastroenterol. 1994; 19: 20-2.
7. Ootsubo C, Okumura T, Takahashi N et al. Helicobacter pylori lipopolysaccharide inhibits acid secretion in pylorus-ligated conscious rats. Biochem. Biophys. Res. Commun. 1997; 236: 532-7.
8. Calam J. Helicobacter pylori modulation of gastric acid (Review). Yale J. Biol. Med. 1999; 72: 195-202.
9. Cheung LY, Ashley SW. Gastric mucosal blood flow and mucosal defence mechanisms. Clin. Invest. Med. 1987; 10: 210-08.
10. Bou-Abboud CF, Wayland H, Paulsen G et al. Microcirculatory stasis precedes tissue necrosis in ethanol-induced gastric mucosal injury in the rat. Dig. Dis. Sci. 1988; 33: 872-7.
11. 2 induces ulceration of gastric mucosa. Nature 1981; 292: 472-4.
12. Beck PL, Morris GP, Wallace JL. Reduction of ethanol-induced gastric damage by sodium cromoglycate and FPL-52694. Role of leukotrienes, prostaglandins and mast cells. Can. J. Pharmacol. 1988; 67: 287-93.
13. 2a and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo. Am. J. Physiol. 1985; 248: G580-G586.
14. 4 in mucosal damage caused by necrotising agents and indomethacin in the rat stomach. Gastroenterology 1991; 100: 619-26.
15. Bjork J, Lindbaum L, Gerdin B et al. Platelet-activating factor increases microvascular permeability and affects endothelial-granulocyte interaction in microvascular beds. Acta Physiol. Scand. 1983; 119: 305-8.
16. Granger DN, Grisham MB, Kvietys PR. Mechanisms of Microvascular Injury. Physiology of the Gastrointestinal Tract. 3rd edn. (ed. LR Johnson.). New York: Raven Press, 1994.
17. Mannaioni PF, Di Bello MG, Masini E. Review. Platelets and inflammation: role of platelet derived growth factor, adhesion molecules and histamine. Inflamm. Res. 1997; 46: 4-18.
18. Kurtel H, Fujimoto K, Zimmerman BJ et al. Ischaemia-reperfusion induced mucosal dysfunction: role of neutrophils. Am. J. Physiol. 1991; 261: G490-G496.
19. Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by NSAIDs is a neutrophil dependent process. Am. J. Physiol. 1990; 259: G462-G467.
20. Tachi K, Goto H, Hayakawa T et al. Prevention of water immersion stress-induced gastric lesions through the enhancement of nitric oxide synthase activity in rats. Aliment. Pharmacol. Ther. 1996; 10: 97-103.
21. Wyatt JI. Histopathology of gastroduodenal inflammation: the impact of Helicobacter pylori. Histopathology 1995; 26: 1-15.
22. Crabtree JE. Immune and inflammatory responses to Helicobacter pylori infection - Review. Scand. J. Gastroenterol. 1996; 215: 3-10.
23. Reymunde A, Deren J, Nachamkin I et al. Production of chemoattractant by Helicobacter pylori. Dig. Dis. Sci. 1993; 38: 1697-701.
24. Kozol R, Domanowski A, Jaszewski R. et al. Neutrophil chemotaxis in gastric mucosa: a signal to response comparison. Dig. Dis. Sci. 1991; 36: 1277-80.
25. Weiss SJ. Tissue destruction by neutrophils. N. Eng. J. Med. 1989; 320: 365-76.
26. Smedley LA, Tonnesen MG, Sandhaus RA et al. Neutrophil-mediated injury to endothelial cells - enhancement by endotoxin and essential role of neutrophil elastase. J. Clin. Invest. 1986; 77: 1233-43.
27. Mai UE, Perez-Perez GI, Allen JB et al. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present within gastric mucosa. J. Exp. Biol. 1992; 175: 517-25.
28. Mai UE, Perez-Perez GI, Wahl LM et al. Soluble surface proteins from Helicobacter pylori activate monocytes and macrophages by LPS-independent mechanism. J. Clin. Invest. 1991; 87: 894-900.
29. Craig PM, Territo MC, Karnes WE et al. Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 1992; 33: 1020-3.
30. Neilsen H, Anderson LP. Chemotactic activity of Helicobacter pylori sonicate for human PMN leukocytes and monocytes. Gut 1992; 33: 738-42.
31. Guth PH, Moler TL. In vivo fluorescence microscopy of the gastric circulation. Gastroenterology 1979; 76: 1147.
32. Guth PH, Rosenburg A. In vivo microscopy of gastric microcirculation. Dig. Dis. 1972; 17: 391-8.
33. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068-88.
34. Talbott GA, Sharar SR, Harlan JM et al. Leukocyte-endothelial interactions and organ injury: the role of adhesion molecules (Review). New Horizons 1994; 2: 545-54.
35. Yoshida N, Granger DN, Evans DJ et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993; 105: 1431-40.
36. Kurose I, Granger DN, Evans DJ et al. Helicobacter pylori-induced microvascular protein leakage in rats: role of neutrophils, mast cells and platelets. Gastroenterology 1994; 104: 70-9.
37. Takemura T, Granger DN, Evans DJ et al. Extract of Helicobacter pylori induces neutrophils to injure endothelial cells and contain anti-elastase activity. Gastroenterology 1996; 110: 21-9.
38. Kalia N, Jacob S, Brown NJ et al. Studies on the gastric mucosal microcirculation. 2. Helicobacter pylori water soluble extracts induce platelet aggregation in the gastric mucosal microcirculation in vivo. Gut 1997; 41: 748-52.
39. Kalia N, Bardhan KD, Reed MW et al. Effects of chronic administration of Helicobacter pylori extracts on rat gastric mucosal microcirculation in vivo. Dig. Dis. Sci. 2000; 45: 1343-51.
40. Page CP. Platelets as inflammatory cells. Immunopharmacology 1989; 17: 51-9.
41. Caccese D, Pratico D, Ghiselli A et al. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation - role of arachidonic acid metabolism. Thromb. Haemost. 2000; 83: 485-90.
42. Collins CE, Rampton DS. Platelet dysfunction: a new dimension in inflammatory bowel disease. Gut 1995; 36: 5-8.
43. Collins CE, Cahill MR, Newland AC et al. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106: 840-5.
44. Clawson CC, White JG. Platelet interaction with bacteria. Am. J. Pathol. 1971; 65: 381-95.
45. Pattichis K, Louca LL. Histamine, histamine H2-receptor antagonists, gastric acid secretion and ulcers: an overview (Review). Drug Metabol. Drug Interact. 1995; 12: 1-36.
46. Queiroz DMM, Mendes EN, Rocha GA et al. Histamine concentration of gastric mucosa in Helicobacter pylori positive and negative children. Gut 1991; 32: 464-6.
47. Bechi P, Dei R, Di Bello MG et al. Helicobacter pylori potentiates histamine release from serosal rat mast cells in vitro. Dig. Dis. Sci. 1993; 38: 944-9.
48. Yamamoto J, Watanabe S, Hirose M et al. Role of mast cells as a trigger of inflammation in Helicobacter pylori infection. J. Physiol. Pharmacol. 1999; 50: 17-23.
49. Masini E, Bechi P, Dei R et al. Helicobacter pylori potentiates histamine release from rat serosal mast cells induced by bile acids. Dig. Dis. Sci. 1994; 39: 1493-500.
50. Denizot Y, Sobhani I, Rambaud JC et al. Paf-acether synthesis by Helicobacter pylori. Gut 1990; 31: 1242-5.
51. Kalia N, Bardhan KD, Reed MW et al. Mechanisms of Helicobacter pylori-induced rat gastric mucosal microcirculatory disturbances in vivo. Dig. Dis. Sci. 2000; 45: 763-72.
52. Huseyinov A, Kutukculer N, Aydogdu S et al. Increased gastric production of platelet-activating factor, leukotriene-B4, and tumor necrosis factor-alpha in children with Helicobacter pylori infection. Dig. Dis. Sci. 1999; 44: 675-9.
53. Suzuki H, Miura S, Imaeda H et al. Enhanced levels of chemiluminescence and platelet activating factor in urease-positive gastric ulcers. Free Radic. Biol. Med. 1996; 20: 449-54.
54. Atuma C, Engstrand L, Holm L. Helicobacter pylori reduces gastric mucus secretion and mucosal blood flow in rats. Gastroenterology 1995; 109: 1526-34.
55. Atuma C, Engstrand L, Holm L. Extracts of Helicobacter pylori reduce gastric mucosal blood flow through a Vac A- and Cag A-independent pathway in rats. Scand. J. Gastroenterol. 1998; 33: 1256-61.
56. Atuma C, Engstrand L, Holm L. Helicobacter pylori extracts reduce gastric mucosal blood flow by a nitric oxide-independent but mast cell and platelet activating factor receptor-dependent pathway in rats. Scand. J. Gastroenterol. 1999; 34: 1183-9.
57. Brzozowski T, Konturek PC, Konturek SJ et al. Water extracts of Helicobacter pylori delay healing of chronic gastric ulcers in rats: role of cytokines and gastrin-somatostatin link. Digestion 1999; 60: 22-33.
58. Brzozowski T, Konturek PC, Konturek SJ et al. Gastric secretion and ulcer healing in mouse stomach infected with cytotoxin expressing strain of Helicobacter pylori. J. Physiol. Pharmacol. 1998; 49: 387-403.
59. Konturek PC, Brzozowski T, Konturek SJ et al. Mouse model of Helicobacter pylori infection: studies of gastric function and ulcer healing. Aliment. Pharmacol. Ther. 1999; 13: 333-46.
60. Kalia N, Bardhan KD, Reed MWR et al. The effects of genotypically different strains of Helicobacter pylori on microvascular endothelial cells in vitro. Dig. Dis. Sci. 2001; 46: 54-61.
61. Wu DC, Wang WM, Lu CYL et al. The hemodynamic changes of gastroduodenal regional blood flow after Helicobacter pylori eradication in patients with duodenal ulcer scar. Kaohsiung J. Med. Sci. 1999; 15: 19-25.
62. Guslandi M, Sorghi M, Tittobello A. Does Helicobacter pylori affect gastric microcirculation? Ital. J. Gastroenterol. 1994; 24: 383-4.
63. Atherton JC, Peek RM, Tham KT et al. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacrer pylori. Gastroenterology 1997; 112: 92-9.
64. Atherton JC. H. pylori virulence factors (Review). Br. Med. Bull. 1998; 54: 105-20.
65. Peek RM, Miller GG, Tham KT et al. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab. Invest. 1995; 73: 760-70.
66. Kalia N, Bardhan KD, Reed MWR et al. The effects of genotypically different strains of Helicobacter pylori on rat gastric mucosal microcirculation in vivo. Gastroenterology 1999; 116: G0885.
67. Kalia N, Bardhan KD, Atherton JC, Brown NJ. Toxigenic Helicobacter pylori induces changes in the gastric mucosal microciculation in rats. Gut 2002; 51: 641-7.
68. Elizalde JI, Gomez J, Panes J et al. Platelet activation in mice and human Helicobacter pylori infection. J. Clin. Invest. 1997; 100: 996-1005.
69. Mendall MA, Goggin PM, Molineaux N et al. Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart J. 1994; 71: 437-9.
70. Pellicano R, Broutet N, Ponzetto A et al. Helicobacter pylori: from the stomach to the heart (Review). Eur. J. Gastroenterol. Hepatol. 1999; 11: 1335-7.
71. Gunn M, Stephens JC, Thompson JR et al. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000; 84: 267-71.
72. Ding SZ, Cho CH, Lain SK. Helicobacter pylori induces interleukin-8 expression in endothelial cells and the signal pathway is protein tyrosine kinase dependent. Biochem. Biophys. Res. Commun. 1997; 240: 561-5.
73. Kim JS, Jung HC, Kim JM et al. Helicobacter pylori watersoluble surface proteins activate human neutrophils and up-regulate expression of CXC chemokines. Dig. Dis. Sci. 2000; 45: 83-92.
74. Satin B, Del Giudice G, Della Bianca V et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J. Exp. Med. 2000; 191: 1467-76.